FAST Company

Underdog Pharmaceuticals

At Underdog Pharmaceuticals, Inc. (Underdog), our mission is to cure age-related disease by addressing and repairing the underlying damage driving such disease, and we intend to start with the first true diseasemodifying treatment for atherosclerosis. Our core platform emerged from the research laboratories of SENS Research Foundation (SRF), the only non-profit dedicated to the development of comprehensive regenerative medicine solutions for the diseases of aging. In our labs and through our research partners, we have developed a robust, combined computational and synthetic chemistry program, allowing the creation and rapid testing of rationally designed drugs, giving us the tools to challenge the world’s most relentless killer.